Δ9-tetrahydrocannabinol-induced apoptosis in Jurkat leukemia T cell's is regulated by translocation of bad to mitochondria

被引:68
作者
Jia, Wentao
Hegde, Venkatesh L.
Singh, Narendra P.
Sisco, Daniel
Grant, Steven
Nagarkatti, Mitzi
Nagarkatti, Prakash S. [1 ]
机构
[1] Univ S Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA
[2] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23284 USA
[3] Virginia Commonwealth Univ, Dept Med, Richmond, VA 23284 USA
关键词
D O I
10.1158/1541-7786.MCR-05-0193
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Plant-derived cannabinoids, including Delta 9-tetrahydrocannabinol (THC), induce apoptosis in leukemic cells, although the precise mechanism remains unclear. In the current study, we investigated the effect of THC on the upstream and downstream events that modulate the extracellular signal-regulated kinase (ERK) module of mitogen-activated protein kinase pathways primarily in human Jurkat leukemia T cells. The data showed that THC down-regulated Raf-1/mitogen-activated protein kinase/ERK kinase (MEK)/ERK/RSK pathway leading to translocation of Bad to mitochondria. THC also decreased the phosphorylation of Akt. However, no significant association of Bad translocation with phosphatidylinositol 3-kinase/Akt and protein kinase A signaling pathways was noted when treated cells were examined in relation to phosphorylation status of Bad by Western blot and localization of Bad to mitochondria by confocal analysis. Furthermore, THC treatment decreased the Bad phosphorylation at Ser(112) but failed to alter the level of phospho-Bad on site Ser(136) that has been reported to be associated with phosphatidylinositol 3-kinase/Akt signal pathway. Jurkat cells expressing a constitutively active MEK construct were found to be resistant to THC-mediated apoptosis and failed to exhibit decreased phospho-Bad on Ser(112) as well as Bad translocation to mitochondria. Finally, use of Bad small interfering RNA reduced the expression of Bad in Jurkat cells leading to increased resistance to THC-mediated apoptosis. Together, these data suggested that Raf-1/MEK/ERK/RSK-mediated Bad translocation played a critical role in THC-induced apoptosis in Jurkat cells.
引用
收藏
页码:549 / 562
页数:14
相关论文
共 67 条
[31]   Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases [J].
Johnson, GL ;
Lapadat, R .
SCIENCE, 2002, 298 (5600) :1911-1912
[32]  
Korsmeyer SJ, 1999, CANCER RES, V59, p1693S
[33]   Mitochondrial control of cell death [J].
Kroemer, G ;
Reed, JC .
NATURE MEDICINE, 2000, 6 (05) :513-519
[34]   Role of PI3-kinase in Bcl-X induction and apoptosis inhibition mediated by IL-3 or IGF-1 in Baf-3 cells [J].
Leverrier, Y ;
Thomas, J ;
Mathieu, AL ;
Low, W ;
Blanquier, B ;
Marvel, J .
CELL DEATH AND DIFFERENTIATION, 1999, 6 (03) :290-296
[35]   Targeting cannabinoid receptors to treat leukemia:: Role of cross-talk between extrinsic and intrinsic pathways in Δ9-tetrahydrocannabinol (THC)-induced apoptosis of Jurkat cells [J].
Lombard, C ;
Nagarkatti, M ;
Nagarkatti, PS .
LEUKEMIA RESEARCH, 2005, 29 (08) :915-922
[36]   Signal transduction - Taking the rap [J].
Marshall, CJ .
NATURE, 1998, 392 (6676) :553-554
[37]   STRUCTURE OF A CANNABINOID RECEPTOR AND FUNCTIONAL EXPRESSION OF THE CLONED CDNA [J].
MATSUDA, LA ;
LOLAIT, SJ ;
BROWNSTEIN, MJ ;
YOUNG, AC ;
BONNER, TI .
NATURE, 1990, 346 (6284) :561-564
[38]   Δ9-Tetrahydrocannabinol-induced apoptosis in the thymus and spleen as a mechanism of immunosuppression in vitro and in vivo [J].
McKallip, RJ ;
Lombard, C ;
Martin, BR ;
Nagarkatti, M ;
Nagarkatti, PS .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 302 (02) :451-465
[39]   Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease [J].
McKallip, RJ ;
Lombard, C ;
Fisher, M ;
Martin, BR ;
Ryu, SH ;
Grant, S ;
Nagarkatti, PS ;
Nagarkatti, M .
BLOOD, 2002, 100 (02) :627-634
[40]   Involvement of the cAMP/protein kinase A pathway and of mitogen-activated protein kinase in the anti-proliferative effects of anandamide in human breast cancer cells [J].
Melck, D ;
Rueda, D ;
Galve-Roperh, I ;
De Petrocellis, L ;
Guzmán, M ;
Di Marzo, V .
FEBS LETTERS, 1999, 463 (03) :235-240